Becton, Dickinson (BDX) | Financial Analysis & Statements
Becton, Dickinson and Company Large-cap Healthcare
TL;DR: Financial Overview - Revenue, Profits & Key Metrics
Latest Quarterly: Dec 2025Income Metrics
Revenue
5.3B
Gross Profit
2.4B
45.91%
Operating Income
662.0M
12.60%
Net Income
382.0M
7.27%
EPS (Diluted)
$1.34
Balance Sheet Metrics
Total Assets
54.8B
Total Liabilities
29.6B
Shareholders Equity
25.3B
Debt to Equity
1.17
Cash Flow Metrics
Operating Cash Flow
1.1B
Free Cash Flow
1.0B
Revenue & Profitability Trend
Quarter Income Flow
Dec 31, 2025
Annual Income Flow
2025
Becton, Dickinson Income Statement From 2021 to 2025
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Revenue | 21.8B | 20.2B | 19.4B | 18.9B | 19.1B |
| Cost of Goods Sold | 11.9B | 11.1B | 11.2B | 10.4B | 10.5B |
| Gross Profit | 9.9B | 9.1B | 8.2B | 8.5B | 8.6B |
| Gross Margin % | 45.4% | 45.2% | 42.2% | 44.9% | 45.1% |
| Operating Expenses | |||||
| Research & Development | 1.3B | 1.2B | 1.2B | 1.3B | 1.3B |
| Selling, General & Administrative | 5.3B | 4.9B | 4.7B | 4.7B | 4.7B |
| Other Operating Expenses | 396.0M | 222.0M | -210.0M | 37.0M | 203.0M |
| Total Operating Expenses | 6.9B | 6.3B | 5.7B | 6.0B | 6.2B |
| Operating Income | 3.0B | 2.9B | 2.4B | 2.5B | 2.4B |
| Operating Margin % | 13.7% | 14.2% | 12.5% | 13.1% | 12.7% |
| Non-Operating Items | |||||
| Interest Income | 38.0M | 163.0M | 49.0M | 16.0M | 9.0M |
| Interest Expense | 613.0M | 528.0M | 452.0M | 398.0M | 469.0M |
| Other Non-Operating Income | -531.0M | -486.0M | -359.0M | -308.0M | -277.0M |
| Pre-tax Income | 1.9B | 2.0B | 1.7B | 1.8B | 1.7B |
| Income Tax | 203.0M | 300.0M | 132.0M | 148.0M | 88.0M |
| Effective Tax Rate % | 10.8% | 15.0% | 7.9% | 8.3% | 5.2% |
| Net Income | 1.7B | 1.7B | 1.5B | 1.8B | 2.1B |
| Net Margin % | 7.7% | 8.4% | 7.7% | 9.4% | 10.9% |
| Key Metrics | |||||
| EBITDA | 5.4B | 5.3B | 4.8B | 4.7B | 4.7B |
| EPS (Basic) | $5.83 | $5.96 | $4.97 | $5.93 | $6.92 |
| EPS (Diluted) | $5.82 | $5.93 | $4.94 | $5.88 | $6.85 |
| Basic Shares Outstanding | 287648000 | 289763000 | 286282000 | 285005000 | 289288000 |
| Diluted Shares Outstanding | 287648000 | 289763000 | 286282000 | 285005000 | 289288000 |
Income Statement Trend
Join Our United States Telegram Channel
Get Instant Market Updates: 52-Week High/Low Alerts, Breakout Notifications & Expert Stock Analysis Delivered To Your Phone. Join Traders Making Informed Decisions Daily!
Becton, Dickinson Balance Sheet From 2021 to 2025
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Assets | |||||
| Current Assets | |||||
| Cash & Equivalents | 641.0M | 1.7B | 1.4B | 1.0B | 2.3B |
| Short-term Investments | 8.0M | 445.0M | 8.0M | 8.0M | 12.0M |
| Accounts Receivable | 3.0B | 3.0B | 2.5B | 2.2B | 2.4B |
| Inventory | 3.9B | 3.8B | 3.3B | 3.2B | 2.7B |
| Other Current Assets | 1.5B | 1.3B | 1.4B | 1.6B | 1.0B |
| Total Current Assets | 9.3B | 10.5B | 8.7B | 8.1B | 8.8B |
| Non-Current Assets | |||||
| Property, Plant & Equipment | 0 | -1.0M | 0 | 1.0M | 1.0M |
| Goodwill | 62.6B | 63.8B | 60.0B | 61.6B | 60.6B |
| Intangible Assets | 9.4B | 10.9B | 10.9B | 12.3B | 12.8B |
| Long-term Investments | - | - | - | - | - |
| Other Non-Current Assets | 3.1B | 2.6B | 2.1B | 1.8B | 2.4B |
| Total Non-Current Assets | 46.1B | 46.8B | 44.1B | 44.8B | 45.0B |
| Total Assets | 55.3B | 57.3B | 52.8B | 52.9B | 53.9B |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts Payable | 2.0B | 1.9B | 1.6B | 1.7B | 1.7B |
| Short-term Debt | 1.6B | 2.2B | 1.1B | 2.2B | 500.0M |
| Current Portion of Long-term Debt | - | - | - | - | - |
| Other Current Liabilities | 1.0M | - | 1.0M | - | 156.0M |
| Total Current Liabilities | 8.3B | 9.0B | 6.6B | 7.8B | 6.6B |
| Non-Current Liabilities | |||||
| Long-term Debt | 17.6B | 17.9B | 14.7B | 13.9B | 17.1B |
| Deferred Tax Liabilities | - | - | - | 5.1B | 5.2B |
| Other Non-Current Liabilities | 2.9B | 3.6B | 4.6B | 5.1B | 5.2B |
| Total Non-Current Liabilities | 21.6B | 22.4B | 20.3B | 19.8B | 23.6B |
| Total Liabilities | 29.9B | 31.4B | 27.0B | 27.7B | 30.2B |
| Equity | |||||
| Common Stock | 371.0M | 371.0M | 371.0M | 365.0M | 365.0M |
| Retained Earnings | 16.6B | 16.1B | 15.5B | 15.2B | 13.8B |
| Treasury Stock | 9.8B | 8.8B | 8.3B | 8.3B | 7.7B |
| Other Equity | - | - | - | - | - |
| Total Shareholders Equity | 25.4B | 25.9B | 25.8B | 25.3B | 23.7B |
| Key Metrics | |||||
| Total Debt | 19.2B | 20.1B | 15.9B | 16.1B | 17.6B |
| Working Capital | 942.0M | 1.5B | 2.0B | 330.0M | 2.2B |
Balance Sheet Composition
Becton, Dickinson Cash Flow Statement From 2021 to 2025
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Operating Activities | |||||
| Net Income | 1.7B | 1.7B | 1.5B | 1.6B | 1.6B |
| Depreciation & Amortization | 2.5B | 2.3B | 2.3B | 2.2B | 2.2B |
| Stock-Based Compensation | 258.0M | 247.0M | 259.0M | 233.0M | 229.0M |
| Working Capital Changes | -524.0M | 270.0M | -822.0M | -1.1B | 516.0M |
| Operating Cash Flow | 3.7B | 3.9B | 3.0B | 3.0B | 4.2B |
| Investing Activities | |||||
| Capital Expenditures | - | - | - | - | - |
| Acquisitions | 0 | -3.9B | 540.0M | -2.1B | -508.0M |
| Investment Purchases | - | -421.0M | 0 | 0 | - |
| Investment Sales | - | - | - | - | - |
| Investing Cash Flow | -480.0M | -4.8B | 158.0M | -2.2B | -649.0M |
| Financing Activities | |||||
| Share Repurchases | - | - | - | -500.0M | -1.8B |
| Dividends Paid | -1.2B | -1.1B | -1.1B | -1.1B | -1.0B |
| Debt Issuance | 0 | 4.5B | 1.7B | 497.0M | 4.9B |
| Debt Repayment | -1.8B | -1.1B | -2.2B | -805.0M | -5.1B |
| Financing Cash Flow | -2.6B | 2.6B | -2.0B | -736.0M | -3.3B |
| Free Cash Flow | 2.7B | 3.1B | 2.1B | 1.7B | 3.5B |
| Net Change in Cash | 587.0M | 1.7B | 1.2B | -22.0M | 270.0M |
Cash Flow Trend
Becton, Dickinson Key Financial Ratios
Valuation Ratios
P/E Ratio (TTM)
25.40
Forward P/E
11.53
Price to Book
1.75
Price to Sales
2.57
PEG Ratio
0.92
Profitability Ratios
Profit Margin
8.01%
Operating Margin
13.35%
Return on Equity
6.96%
Return on Assets
4.08%
Financial Health
Current Ratio
1.05
Debt to Equity
77.28
Beta
0.35
Per Share Data
EPS (TTM)
$6.13
Book Value per Share
$88.79
Revenue per Share
$76.48
Peer Financial Comparison
| Company | Market Cap | P/E Ratio | P/B Ratio | ROE | Profit Margin | Debt/Equity |
|---|---|---|---|---|---|---|
| BDX | 56.1B | 25.40 | 1.75 | 6.96% | 8.01% | 77.28 |
| Intuitive Surgical | 170.1B | 54.97 | 8.99 | 16.69% | 28.38% | 0.95 |
| Alcon | 45.8B | 40.84 | 2.07 | 5.23% | 11.28% | 23.63 |
| ResMed | 32.0B | 21.69 | 5.06 | 25.68% | 27.53% | 13.41 |
| West Pharmaceutical | 22.1B | 40.99 | 6.94 | 19.13% | 16.85% | 10.73 |
| Hologic | 17.0B | 31.54 | 3.23 | 10.86% | 13.18% | 48.05 |
Financial data is updated regularly. All figures are in the company's reporting currency.






